| ¿µ¹® | cholinergic | ÇÑ±Û | Äݸ°(ÀÛµ¿)¼º |
|---|---|---|---|
| ¼³¸í | 1.½Å°æ¼¼Æ÷°¡ ´Ù¸¥ ½Å°æ¼¼Æ÷·Î Á¤º¸¸¦ Àü´ÞÇÒ °æ¿ì¿¡´Â ´ëºÎºÐ ÈÇй°ÁúÀ» ºÐºñÇÏ¿© ±×°ÍÀ» ¸Å°³·Î ÇÏ¿© ´Ù¸¥ ½Å°æ¿¡ Á¤º¸¸¦ Àü´ÞÇÑ´Ù. ÀÌ·± ¹°ÁúÀ» ½Å°æÀü´Þ¹°Áú¶ó°í ÇÑ´Ù. Äݸ°¼ºÀ̶õ ½Å°æÀü´Þ¹°Áú·Î acetylcholineÀ» »ç¿ëÇÏ´Â ½Å°æÀ» À̸£´Â ¸»ÀÌ´Ù. Áï ºÎ±³°¨½Å°æÀ» À̸£´Â ¸»·Î ¾²ÀδÙ. 2. Acetylcholine°ú À¯»çÇÑ ¾à¸®Àû ÀÛ¿ëÀ» ÇÏ´Â. |
||
| DA | Dopamine agonists |
|---|---|
| GnRHa | Gonadotrophin releasing hormone agonists |
| CBF | Cholinergic basal forebrain |
| HCNP | Hippocampal cholinergic neurostimulating peptide |
| mAChR | Muscarinic cholinergic receptors |
| cholinergic agonists | Drugs that bind to and activate cholinergic receptors. (12 Dec 1998) |
|---|
| adrenergic agonists | Drugs that bind to and activate adrenergic receptors. (12 Dec 1998) |
|---|---|
| adrenergic alpha-agonists | Drugs that selectively bind to and activate alpha adrenergic receptors. (12 Dec 1998) |
| adrenergic beta-agonists | Drugs that selectively bind to and activate beta-adrenergic receptors. (12 Dec 1998) |
| gaba agonists | Drugs that bind to and activate gaba receptors (receptors, gaba). (12 Dec 1998) |
| myeloablative agonists | Agents that destroy bone marrow activity. They are used to prepare patients for bone marrow or stem cell transplantation. (12 Dec 1998) |
| serotonin agonists | Agents that have an affinity for serotonin receptors and are able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. These compounds are used as antidepressants, anxiolytics, and in the treatment of migraine. (12 Dec 1998) |
| nicotinic agonists | Drugs that bind to and activate nicotinic cholinergic receptors (receptors, nicotinic). Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. Agents that function as neuromuscular depolarising blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission. (12 Dec 1998) |
| dopamine agonists | Drugs that bind to and activate dopamine receptors. (12 Dec 1998) |
| excitatory amino acid agonists | Drugs that bind to and activate excitatory amino acid receptors. (12 Dec 1998) |
| lhrh agonists | Compounds that are similar to LHRH (luteinizing hormone-releasing hormone). (12 Dec 1998) |
| receptors, cholinergic | Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behaviour of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology. (12 Dec 1998) |
| cholinergic | <pharmacology> Resembling acetylcholine in pharmacological action, stimulated by or releasing acetylcholine or a related compound. (15 Jan 1998) |
| cholinergic agent | An agent that mimics the action of the parasympathetic nervous system (e.g., methacholine). (05 Mar 2000) |
| cholinergic agents | Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of acetylcholine, and drugs that affect the survival of cholinergic neurons. The term cholinergic agents is sometimes still used in the narrower sense of muscarinic agonist, although most modern texts discourage that usage. (12 Dec 1998) |
| cholinergic antagonists | Drugs that bind to but do not activate cholinergic receptors, thereby blocking the actions of acetylcholine or cholinergic agonists. (12 Dec 1998) |
Synonyms : Acetylcholine Agonist, Cholinergic Agonist, Agonist, Acetylcholine, Agonist, Cholinergic, Agonists, Acetylcholine, Agonists, Cholinergic
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|